Gliclazide attenuates the intracellular Ca2+ changes induced in vitro by ischemia in the retinal slices of rats with streptozotocin-induced diabetes

Current Eye Research

Volumn 30, Issue 9, 2005, Pages 789-798

  Kinukawa, Jiro ^a   Shimura, Masahiko ^a,b   Harata, Nobutoshi ^c   Tamai, Makoto ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NTT East Tohoku Hospital   (Japan)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Diabetes; Gliclazide; Intracellular Ca2+; Ischemia; Slice retina

Indexed keywords

CALCIUM; GLIBENCLAMIDE; GLICLAZIDE; GLUCOSE; IONOPHORE; OXYGEN; SCAVENGER; STREPTOZOCIN; SULFONYLUREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT; RETINA; RETINA ISCHEMIA; STREPTOZOCIN DIABETES;

ANILINE COMPOUNDS; ANIMALS; CALCIUM; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; GLICLAZIDE; GLYBURIDE; HYPOGLYCEMIC AGENTS; IONOMYCIN; IONOPHORES; ISCHEMIA; MICROSCOPY, CONFOCAL; RATS; RATS, SPRAGUE-DAWLEY; RETINA; STREPTOZOCIN; XANTHENES;

EID: 26444446994     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680591002808     Document Type: Article

References (42)

1. Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology. 1998;105:998-1003.
2. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Eng J Med. 2000;342:381-389.
3. Kowluru RA, Jirousek MR, Stramm L, Farid N, Engerman RL, Kern TS. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. V. Relationship between protein kinase C and ATPases. Diabetes. 1998;47:464-469.
4. i in renal proximal tubular cells. Kidney Int. 1998;54:1206-1213.
5. Boldizsar F, Berki T, Miseta A, Nemeth P. Effect of hyperglycemia on the basal cytosolic free calcium level, calcium signal and tyrosine-phosphorylation in human T-cells. Immunol Lett. 2002;82:159-164.
6. Pang Y, Hunton DL, Bounelis P, Marchase RB. Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes. Diabetes. 2002;51:3461-3467.
7. Tolentino MJ, Adamis AP. Angiogenic factors in the development of diabetic iris neovascularization and retinopathy. Int Ophthalmol Clin. 1998;38:77-94.
8. Lee P, Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol. 1998;43:245-269.
9. Choi DW. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 1995;18:58-60.
10. 2+ changes induced by in vitro ischemia in rat retinal slices. Exp Eye Res. 2001;73:365-374.
11. Jennings PE, Scott NA, Saniabadi AR, Belch JJ. Effects of gliclazide on platelet reactivity and free radicals in type II diabetic patients: clinical assessment. Metabolism. 1992;41:36-39.
12. Noda Y, Mori A, Packer L. Gliclazide scavenges hydroxyl, superoxide and nitric oxide radicals: an ESR study. Res Commun Mol Pathol Pharmacol. 1997;96:115-124.
13. O'Brien RC, Luo M, Balazs N, Mercuri J. In vitro and in vivo antioxidant properties of gliclazide. J Diabetes Complications. 2000;14:201-206.
14. Desfaits AC, Serri O, Reiner G. Gliclazide decreases cell-mediated low density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL. Metabolism. 1997;46:1150-1156.
15. Shinzato T, Shimabukuro M, Higa S, Nagamine F, Murakami K, Takasu N. Effect of gliclazide on the functional response to calcium in diabetic rat heart. Gen Pharmacol. 1996;27:471-475.
16. Kinukawa Y, Shimura M, Tamai M. Quantifying leukocyte dynamics and plugging in retinal microcirculation of streptozotocin-induced diabetic rats. Curr Eye Res. 1999;18:49-55.
17. Qiang X, Satoh J, Sagara M, Fukuzawa M, Masuda T, Miyaguchi S, Takahashi K, Toyota T. Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats. Metabolism. 1998;47:977-981.
18. Onozato ML, Tojo A, Goto A, Fujita T. Radial scavenging effect of gliclazide in diabetic rats fed with a high cholesterol diet. Kidney Int. 2004;65:951-960.
19. Kinoshita N, Kakehashi A, Inoda S, Itou Y, Kuroki M, Yasu T, Kawakami M, Kanazawa Y. Effective and selective prevention of retinal leukostasis in streptozotocin-induced diabetic rats using gliclazide. Diabetologia. 2002;45:735-739.
20. Kimoto K, Suzuki K, Kizaki T, Hitomi Y, Ishida H, Katsura H, Itoh E, Ookawara T, Suzuki K, Honke K, et al. Gliclazide protects zpancreatic β-cells from damage by hydrogen peroxide. Biochem Biophys Res Commun. 2003;303:112-119.
21. Stricker SA, Three-dimensional confocal microscopy. In: Stevens JK, Mills LR, Trogadis JE. Investigation of Biological Systems. San Diego: Academic, 1994.
22. El-Matbouli M, Holstein TW, Hoffmann R. Determination of nuclear DNA concentration in cells of Myxobolus cerebralis and triactinomyxon spores, the causative agent of whirling disease. Parasitol Res. 1998;84:694-699.
23. de Graaf IM, Jakobs ME, Leschot NJ, Ravkin I, Goldbard S, Hoovers JM. Enrichment, identification and analysis of fetal cells from maternal blood: evaluation of a prenatal diagnosis system. Prenat Diagn. 1999;19:648-652.
24. Clay CE, Namen AM, Atsumi G, Willingham MC, High KP, Kute TE, Trimboli AJ, Fouteh AN, Dawson PA, Chilton FH. Influence of J series prostagrandins on apoptosis and tumorigenesis of breast cancer cells. Carcinogenesis. 1999;20:1905-1911.
25. Cohen AI, The retina. In: Cohen AI. Adler's Physiology of the Eye. St. Louis: Mosby-Year Book Inc., 1992:579-615.
26. Miyamoto K, Hiroshiba N, Tsujikawa A, Ogura Y. In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic human retina and choroid. Invest Ophthalmol Vis Sci. 1998;39:2190-2194.
27. McLeod DS, Lefer DJ, Merges C, Lutty GA. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol. 1995;147:642-653.
28. Schroder S, Palinski W, Scmid-Schonbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol. 1991;139:81-100.
29. Shirao Y, Kawasaki K. Electrical responses from diabetic retina. Prog Retinal Res. 1998;17:59-76.
30. Singh M, Savitz SI, Hoque R, Gupta G, Roth S, Rosenbaum PS, Rosenbaum DM. Cell-specific caspase expression by different neuronal phenotypes in transient retinal ischemia. J Neurochem. 2001;77:466-475.
31. Rosenbaum DM, Rosenbaum PS, Singh M, Gupta G, Gupta H, Li B, Roth S. Functional and morphologic comparison of two method to produce transient retinal ischemia in the rat. J Neuro-Ophthalmol. 2001;21:62-68.
32. Geyer O, Almog J, Lupu-Meiri M, Lazar N, Oron Y. Nitric oxide synthase inhibitors protect rat retina against ischemic injury. FEBS Lett. 1995;374:399-402.
33. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature. 2000;407:802-809.
34. Yu SP, Canzoniero LM, Choi DW. Ion homeostasis and apoptosis. Curr Opin Cell Biol. 2001;13:405-411.
35. Desfaits AC, Serri O, Reiner G. Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-a production in NIDDM patients after gliclazide treatment. Diabetes Care. 1998;21:487-493.
36. Pagano PJ, Griswold MC, Ravel D, Cohen RA. Vascular action of the hypoglycaemic agent gliclazide in diabetic rabbits. Diabetologia. 1998;41:9-15.
37. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes. 1999;48:1-9.
38. Watts GF, Playford DA. Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: and hypothesis. Artherosclerosis. 1998;141:17-30.
39. Hammes HP, Bartmann A, Engel L, Wulfroth P. Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine. Diabetologia. 1997;40:629-634.
40. Ansari NH, Zhang W, Fulep E, Mansour A. Prevention of pericyte loss induced by trolox in diabetic rat retina. J Toxicol Environ Health. 1998;54:467-475.
41. Bursell S, Clermont A, Aiello LP, Aiello LM, Laffel L. Vitamin E treatment normalizes retinal blood flow and improves renal function in IDDM patients: results of a double masked crossover clinical trial. Diabetes. 1998;47:A100.
42. 2+ influx in cultured rat mesangial cells by a protein kinase C-dependent mechanism. Diabetologia. 1997;40:521-527.